Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
60%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
OZEM
21
HOLDINGS
62%
ALSO IN THNR
THNR
18
HOLDINGS
76%
ALSO IN OZEM
SECTOR DRIFT (OZEM minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in OZEM |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 18.2% | 13.8% | 13.8% | |
| NOVO-NORDISK A/S-SPONS ADR | 13.1% | 14.6% | 13.1% | |
| PFIZER INC | 6.4% | 4.7% | 4.7% | |
| CHUGAI PHARMACEUTICAL CO LTD | 4.3% | 5.4% | 4.3% | |
| CHINA PHARMACEUTICAL GROUP | 4.5% | 4.1% | 4.1% | |
OZEM Overweight Relative to THNR
| ELI LILLY & CO | 4.4% | |
| ASCLETIS PHARMA, INC. | 3.3% | |
| HANMI PHARM CO LTD | 2.8% | |
| VIKING THERAPEUTICS, INC. | 2.6% | |
| THE UNITED LABORATORIES INTE | 2.4% | |
| ZEALAND PHARMA A/S | 2.2% | |
| MBX BIOSCIENCES INC | 2.1% | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMP | 1.8% | |
| GILEAD SCIENCES INC | 1.7% | |
| PFIZER INC | 1.7% |
OZEM Underweight Relative to THNR
| ARROWHEAD PHARMACEUTICALS, INC. | -6.0% | |
| MERCK & CO. INC. | -4.9% | |
| ABBVIE INC | -4.7% | |
| SHIONOGI & CO LTD | -3.0% | |
| REGENERON PHARMACEUTICALS | -2.9% | |
| AMGEN INC | -2.4% | |
| SCHOLAR ROCK HOLDING CORP. | -2.3% | |
| NOVO-NORDISK A/S-SPONS ADR | -1.5% | |
| ASTRAZENECA PLC | -1.4% | |
| CHUGAI PHARMACEUTICAL CO LTD | -1.1% |